drugset / Trial / NCT00775658

Olopatadine Eye Drops and Allergy Skin Testing

NCT00775658

Completed 24 enrolled Vanderbilt University Medical Center
RandomizedCrossoverDouble-blindDiagnostic

Summary

Use of olopatadine ophthalmic solution (eye drops) will decrease allergy skin test reactivity.

Timeline

Start
2008-01
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Olopatadine Other / unclassified 0.2 % Other